SCIENTIFIC PROGRAM
September 12, 2025 Friday
September 13, 2025 Saturday
September 14, 2025 Sunday
| Time(CST) | |||
|---|---|---|---|
| 07:00-07:50 | Registration | ||
| 07:50-08:00 | Welcome note | ||
| Hall A | Hall B | ||
| 08:00-09:15 | Scientific Session 1a Theme: Prophylaxis |
Scientific Session 1b Theme: Musculoskeletal Management in Haemophilia |
|
| Co Chairs: Heng Joo Ng, Singapore General Hospital, Singapore Ching-Tien Peng, China Medical University Hospital, Taichung |
Co Chairs: Kumiko Ono, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Ta-Sen Wei, Changhua Christian Hospital, Changhua |
||
| 08:00-08:25 |
Alternate dosing strategies of factor mimetics.
Speaker: Nuchanun Kessakorn, Synphaet Hospital, Nakhonpathom Province, Nakhonpathom.
|
Ultrasound in Joint Health Monitoring.
Speaker: Marcel Prasetyo, Dr. Cipto Mangunkusumo Hospital, Jakarta
|
|
| 08:25-08:50 |
Updates on low-dose prophylaxis in Asia Pacific region.
Speaker: Novie Chozie, Dr. Cipto Mangunkusumo Hospital Jakarta, Jakarta.
|
Physical Activity in children with haemophilia.
Speaker: Judy Ann David, Christian Medical College Vellore, Vellore
|
|
| 08:50-09:15 |
Impact of Prophylaxis on Factor and non-factor Utilization and Cost-Effectiveness.
Speaker: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung.
|
Pain Management in Chronic Joint Arthropathy.
Speaker: Yusuke Inagaki, Nara Medical University, Nara
|
|
| 09:20-10:10 | Scientific Session 2a Theme: Bleeding Disorders of Unknown Cause |
Scientific Session 2b Theme: Nursing |
|
| Co Chairs: Zulaiha Muda, Hospital Tunku Azizah Women Children Hospital, Kuala Lumpur Hui-Chi Hsu, Cheng Hsin General Hospital, Taipei |
Chair: Lim Chiew Ying, KK Women's and Children's Hospital, Singapore |
||
| 09:20-09:45 |
Approach to diagnosis of patients with bleeding disorders of unknown cause
Speaker: Dino Mehic, Medical University of Vienna, Vienna
|
Understanding Women with Bleeding Disorder.
Speaker: Penny McCarthy, The Alfred hospital, Melbourne.
|
|
| 09:45-10:10 |
Management of bleeding disorders with unknown cause
Speaker: Floor Heubel-Moenen, Maastricht University Medical Center, Maastricht (Virtual)
|
Enhancing patient outcomes: The role of the Nurse in Clinical Trials.
Speaker: Abraham Sunder Singh, Christian Medical College Vellore, Vellore.
|
|
| 10:10-10:40 | Tea Break with Poster viewing | ||
| Hall A | |||
| 10:40-11:20 | Plenary 1 | ||
| Co Chairs: Darintr Sosothikul, Chulalongkorn University, Bangkok Ming-Ching Shen, Changhua Christian Hospital, Changhua |
|||
| 10:40-11:10 |
Rebalancing agents for Haemostasis and new paradigm for Haemophilia care.
Speaker: Tadashi Matsushita, Nagoya University, Nagoya |
||
| 11:10-11:20 | Discussion | ||
| Hall A | |||
| 11:20-12:20 |
AHAD-AP Educational Symposium- Supported by Takeda
Chair: Alok Srivastava, St. John's Medical College Hospital, Bengaluru |
||
| 11:20-11:22 |
Welcome and Introduction
|
||
| 11:22-11:37 |
Rationale for bypassing agents with different mechanisms of action in treatment of bleeds.
Speaker: Alok Srivastava, St. John's Medical College Hospital, Bengaluru |
||
| 11:37-11:52 |
Bypass agents for management of breakthrough bleeds patients with inhibitors on non-factor therapies.
Speaker: Darintr Sosothikul, Chulalongkorn University, Bangkok. |
||
| 11:52-12:07 |
Haemostasis management with bypass agents for surgery in patients with inhibitors receiving non-factor therapies.
Speaker: Heng Joo Ng, Singapore General Hospital, Singapore. |
||
| 12:07-12:20 |
Discussion
|
||
| 12:20-13:20 | Lunch | ||
| Hall A | Hall B | ||
| 13:20-14:35 | Scientific Session 3a Theme: Ageing and Lifestyle Disorders in haemophilia |
Scientific Session 3b Theme: Laboratory |
|
| Co Chairs: Liane Khoo, Royal Prince Alfred Hospital, Sydney Dong-Tsamn Lin, Taiwan University Hospital, Taipei |
Co Chairs: Tien Sim Leng, Singapore General Hospital, Singapore. Ajay Gandhi, BLK-Max Superspeciality Hospital, New Delhi. |
||
| 13:20-13:45 |
Cardiovascular Health in Ageing Haemophilia Patients.
Speaker: Sang Min Park, Eulji University School of Medicine, Seoul.
|
13:20-13:35 |
Laboratory monitoring for PwH on factor mimetics (Fitusiran/Emicizumab/Concizumab)
Speaker: Nitty S Mathews, Christian Medical College Vellore, Vellore.
|
| 13:45-14:10 |
Bone Health and Osteoporosis in Haemophilia.
Speaker: Ayse Zengin, The Alfred hospital & Monash Medical Centre, Melbourne.
|
13:35-13:50 |
When is Inhibitor Positive a False Positive and Prevention-Simpler Tools
Speaker: Sukesh C Nair, Christian Medical College Vellore, Vellore.
|
| 14:10-14:35 |
HR-QOL & Cognitive Function in Haemophilia.
Speaker: Raymond Wong, The Chinese University of Hongkong, Hongkong.
|
13:50-14:35 |
Diagnosis of VWD at Various settings: Experience Sharing. (10 minutes each)
a) Hermi Indita Malewa, RSUD Prof Dr WZ Johannes Kupang NTT, Kupang.
b) Chandima Thevarapperuma, Lady Ridgway hospital, Colombo.
c) Dinesh Chandra, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow
Summary of solutions and more cost effective methods towards VWD diagnosis – 5 minutes
Q&A – 10 minutes
|
| Hall A | |||
| 14:40-15:40 |
Sponsored Symposium: Sanofi
Chair: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung |
||
| 14:40-14:45 |
Welcome and introduction
Chair: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung
|
||
| 14:45-15:05 |
Latest on rebalancing agents in hemophilia care
Speaker: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung
|
||
| 15:05-15:20 |
How can we integrate rebalancing agents into clinical practice?
Speaker: Alok Srivastava, St. John's Medical College Hospital, Bengaluru.
|
||
| 15:25-15:40 |
Expert insights on hemophilia management with rebalancing agents: An interactive discussion with Q&A
Panelist: Sheng-Chieh Chou, National Taiwan University Hospital, Taipei.
|
||
| 15:40-16:10 | Tea Break with Poster viewing | ||
| 16:10-17:00 | Scientific Session 4a Theme: Surgery in haemophilia |
Scientific Session 4b Theme: Women with bleeding disorders |
|
| Co Chairs: Chee Wee Tan, Royal Adelaide Hospital, Adelaide Shih-Chung Wang, Changhua Christian Children's Hospital, Changhua |
Co Chairs: Nguyen Thi Mai, National Institute of Hematology and Blood Transfusion General, Hanoi Pei-Chin Lin, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung |
||
| 16:10-16:35 |
Haemostasis Management during Surgery.
Speaker: Jiaan-Der Wang, Taichung Veterans General Hospital, Taichung.
|
Diagnosis and Care of Women and Girls with Haemophilia
Speaker: Roseline d'Oiron, Bicetre Hospital, Paris (Virtual)
|
|
| 16:35-17:00 |
Surgery in Patients receiving Non-factor Therapy.
Speaker: Yushi Chikasawa, Tokyo Medical University Hospital, Tokyo.
|
Management of Inherited Bleeding Disorders in Pregnancy.
Speaker: Chuen Wen Tan, Singapore General Hospital, Singapore.
|
|
| Time(CST) | Hall A | Hall B | |
|---|---|---|---|
| 08:00-09:15 | Scientific Session 5a Theme: Genetics of Inherited Bleeding Disorders |
Scientific Session 5b Theme: Nursing Management of Acute Haemathrosis: Beyond Factor Coverage |
|
|
Co Chairs:
Ma. Angelina Mirasol, University of the Philippines Philippine General Hospital, Manila
Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiunga
|
Chair: Dita Rizkiya Yusnita, Dr Cipto Mangunkusumo hospital, Jakarta |
||
| 08:00-08:25 |
Genetic of Inherited Bleeding Disorders- Current Technologies.
Speaker: Nguyen Thanh Ngoc Binh, National Institute of Haematology and Blood Transfusion, Hanoi.
|
Counselling at Diagnosis of Bleeding Disorders.
Speaker: Yu-Ting Hsu, Changhua Christian Hospital, Changhua
|
|
| 08:25-08:50 |
Variant Origin of Sporadic Haemophilia A.
Speaker: Ming-Ching Shen, Changhua Christian Hospital, Changhua.
|
Home based Care for Bleeding Disorders: Strategies to Empower Families.
Speaker: Sulochana B, Manipal College of Nursing, Manipal.
|
|
| 08:50-09:15 |
Genetic Analysis of Carrier Status in Female Members.
Speaker: Keiko Shinozawa, Tokyo Medical University Hospital, Tokyo.
|
Adolescents and transition to Adult Care: Ensuring continuity and preparedness/ Nursing Management of Acute Haemathrosis.
Speaker: Prathiba Purshotaman, Penang General Hospital, Penang.
|
|
| 09:20-10:10 | Scientific Session 6a Theme: Inhibitor Management |
Scientific Session 6b Theme: Comprehensive Care: Current Trends |
|
| Co Chairs: Shiue-Wei Lai, Tri-service General Hospital, Taipei Neeraj Sidharthan, Amrita Institute of Medical Sciences Kochi, Kochi
|
Co Chairs: Sandeep Albert, Christian Medical College Vellore, VelloreChing-Yeh Lin, Wuri Lin Shin Hospital, Taichung |
||
| 09:20-09:40 |
Current Management of Inhibitors.
Speaker: Seung-min Hahn, Yonsei University College of Medicine, Seoul.
|
09:20-09:45 |
Comprehensive Care Team in the Era of Novel Therapies.
Speaker: Leonard A Valentino, RushUniversity Medical Center, Chicago (Virtual)
|
| 09:40-10:10 |
Panel Discussion: Management of Inhibitors - Practice Patterns.
1. Chean Sophal, National Pediatric Hospital, Phnom Penh, Phnom Penh.
2. Flerida Hernandez, University of Santo Tomas, Manila. |
09:45-10:10 |
Outcome assessment in the Era of Novel Therapies.
Speaker: Sheng-Chieh Chou, National Taiwan University Hospital, Taipei
|
| 10:10-10:40 | Tea Break with Poster viewing | ||
| Hall A | |||
| 10:40-11:20 | Plenary 2 | ||
| Co Chairs: Alok Srivastava, St. John's Medical College Hospital, Bengaluru Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung |
|||
| 10:40-11:10 |
Gene therapy for Haemophilia- Current Status and Future directions.
Speaker: Wolfgang Miesbach, Frankfurt University Hospital, Frankfurt. (Virtual)
|
||
| 11:10-11:20 | Discussion | ||
| Hall A | |||
| 11:20-12:20 |
Sponsored Symposium: Novo Nordisk APAC
|
||
| 11:20-11:25 |
Introduce the sessions and Prof. Hahn
Chair: Darintr Sosothikul, Chulalongkorn University, Bangkok
|
||
| 11:25-11:45 |
Protecting Joints, Preserving Lives – The Evolv-ing Role of Anti-TFPI in Haemophilia
Speaker: Seung-min Hahn, Yonsei University College of Medicine, Seoul.
|
||
| 11:45-11:50 |
Introduce the sessions and Penny McCarthy
Chair: Darintr Sosothikul, Chulalongkorn University, Bangkok
|
||
| 11:50-12:05 |
Living with Haemophilia in 2025: What Do Patients Want from New Therapies
Speaker: Penny McCarthy, The Alfred hospital, Melbourne.
|
||
| 12:05-12:20 |
Q&A - Panel discussion
|
||
| 12:20-13:20 | Lunch | ||
| Hall A | Hall B | ||
| 13:20-14:35 |
Scientific Session 7a
Theme: Oral Presentation - Clinical |
Scientific Session 7b
Theme: Oral Presentation - Laboratory/MSK/Multi-disciplinary |
|
| Co Chairs: Liane Khoo, Royal Prince Alfred Hospital, Sydney Sheng-Chieh Chou, National Taiwan University Hospital, Taipei |
Co Chairs: Yeu-Chin Chen, Tri-Service General Hospital, Taipei. Judy Ann David, Christian Medical College Vellore, Vellore. |
||
| 13:20-13:32 |
Emicizumab Prophylaxis in Children with Haemophilia A: Experience in Northern Peninsular Malaysia
Presenter: Ming Ang, Penang General Hospital, Pulau Pinang
|
Integrating Clinical, Laboratory, and Genomic Insights in Hemophilia C: A 25-Year Experience from North India
Presenter: Narender Kumar, Post Graduate Institute of Medical Education & Research, Chandigarh
|
|
| 13:32-13:44 |
Efanesoctocog alfa: better protection, longer half-life and shorter activated partial thromboplastin time(aPTT), a single Institute experience
Presenter: Wan-Yi Hsu, Kaohsiung medical university hospital, Kaohsiung
|
Multidimensional Phenotyping of Discrepant Hemophilia A: Bridging Diagnostic Discordance Using Functional and Global Hemostasis Assays
Presenter: Anusha Thangaraja, Christian Medical College, Vellore
|
|
| 13:44-13:56 |
Lower Dose Emicizumab in Pediatric Hemophilia A: Clinical Outcomes and the Utility of Global Hemostasis Assays
Presenter: Neeraj Sidharthan, Amrita Institute of Medical Sciences, Kerala
|
Compliance With Treatment Diary Recording Among Hemophilia Patients and Caregivers at the National Institute of Hematology and Blood Transfusion, Vietnam
Presenter: Thi Hien Pham, National Institute of Hematology and Blood Transfusion, Hà Nội
|
|
| 13:56-14:08 |
The three patients who developed factor VIII inhibitor during efanesoctocog alpha prophylaxis in Japan
Presenter: Satoshi Higasa, Hyogo Medical University Hospital, Nishinomiya
|
A report of self-infusion workshop among patients and caregivers from the Hemophilia Treatment Center in Jakarta, Indonesia
Presenter: Dita Yusnita, Dr. Cipto Mangunkusumo Hospital, Jakarta
|
|
| 14:08-14:20 |
Real-world Experience of Clinical Outcomes of Pre- and Post- Switching to Efanesoctocog alfa Prophylaxis for People with Severe Hemophilia A: A Preliminary Study in Taiwan
Presenter: Chia-Yau Chang, Taipei Medical University Hospital, Taipei
|
An enhanced Functional Independence Score for Haemophilia (e-FISH) for early detection of musculoskeletal changes
Presenter: Priya Srikumar, Christian Medical College, Vellore
|
|
| 14:20-14:32 |
Intracranial hemorrhage in pediatric hemophilia: clinical characteristics, management, and outcomes
Presenter: Tuan Nguyen, Children's Hospital, Ho Chi Minh
|
Joint Health Trajectories in Severe Hemophilia: A Decade of Pettersson Data from Taiwan
Presenter: Te-Fu Weng, Chung Shan Medical University Hospital, Taichung
|
|
| Hall A | Hall B | ||
| 14:40-15:40 |
Sponsored Symposium: Chugai Pharmaceuticals
Co-Chairs:
Jiaan-Der Wang, Taichung Veterans General Hospital, Taichung
Tadashi Matsushita, Nagoya University, Nagoya.
|
Sponsored Symposium: Octa Pharma
Chair: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung
|
|
| 14:40-15:10 |
Improvement in QOL for Hemophilia Patients with Hemlibra ~Clinical Evidence from Japan~
Speaker: Tomoko Yamaguchi, Department of Blood Coagulation, Ogikubo Hospital, Tokyo
|
14:40-14:50 |
Welcome and Introduction
Chair: Shyh-Shin Chiou
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung
|
| 14:50-15:05 |
Latest Insights on Inhibitor Management in Haemophilia A. VWD Prophylaxis: Bridging Gaps for Better Outcomes
Speaker: Carmen Escuriola-Ettingshausen, Rhein Main – HZRM, Frankfurt.
|
||
| 15:10-15:40 |
The Impact of HEMLIBRA on Hemophilia Patients: Lessons Learned from Real-World Experiences
Speaker: Liane Khoo, Royal Prince Alfred Hospital, Sydney.
|
15:05-15:20 |
Personalising Prophylaxis to Advance Care for People
Speaker: Te-Fu Weng, Chung Shan Medical University Hospital, Taichung
|
| 15:20-15:35 |
VWD Prophylaxis: Bridging Gaps for Better Outcomes
Speaker: Carmen Escuriola-Ettingshausen, Rhein Main – HZRM, Frankfurt.
|
||
| 15:35-15:40 |
Q&A and concluding remarks
|
||
| 15:40-16:10 | Tea Break with Poster viewing | ||
| 16:10-17:00 | Scientific Session 8a Theme: Registries and Outcomes Documentation |
Scientific Session 8b Theme: Advanced technology |
|
| Co Chairs: Fitri Primacakti, Dr. Cipto Mangunkusumo Hospital Jakarta, Jakarta Jiann-Shiuh Chen, National Cheng Kung University Hospital, Tainan |
Co Chairs: M Joseph John, Christian Medical College Ludhiana, Ludhiana Ta-Sen Wei, Changhua Christian Hospital, Changhua |
||
| 16:10-16:35 |
Registry Management in Thailand in WBDR.
Speaker: Rungrote Natesiriniku, Chiang Mai Univesity, Chiang Mai.
|
Digital Health Solutions for Haemophilia: Remote Monitoring.
Speaker: Annette von Drygalski, University of California San Diego, San Diego.
|
|
| 16:35-17:00 |
The use of ABR in assessment of haemophilia – Addressing the challenges.
Speaker: Alok Srivastava, St. John's Medical College Hospital, Bengaluru
|
Artificial Intelligence in Imaging.
Speaker: Azusa Nagao, Kansai Medical University Hospital, Osaka.
|
|
| 18:00-20:30 | AHAD-AP ASM-2025 Dinner (Sponsored by Sanofi) | ||
| Time(CST) | Hall A | |
|---|---|---|
| 08:30-09:45 | Scientific Session 9 Theme: Von Willebrand Disease |
|
| Co Chairs: Joyce Lam, KK Women's and Children's Hospital, Singapore Ting-Huan Huang, Hsinchu Municipal Mackay Children’s Hospital, Hsinchu |
||
| 08:30-08:55 |
Application of Bleeding Assessment Tools.
Speaker: Nongnuch Sirachainan, Ramathibodi Hospital, Bangkok.
|
|
| 08:55-09:20 |
Navigating the Maze to Improve Von Willebrand’s Testing.
Speaker: Jasmina Ahluwalia, Postgraduate Institute of Medical Education and Research, Chandigarh.
|
|
| 09:20-09:45 |
Management of Severe von Willebrand Disease.
Speaker: Carmen Escuriola-Ettingshausen, Rhein Main – HZRM, Frankfurt
|
|
| 09:45-10:15 | Tea Break | |
| 10:15-11:30 | Scientific Session 10 Theme: Rare Bleeding Disorders |
|
| Co Chairs: Nitty S Mathews, Christian Medical College Vellore, Vellore Ching-Ping Tseng, Chang Gung University, Taoyuan |
||
| 10:15-10:40 |
Management of Rare Factor Deficiencies.
Speaker: Hsuan-Yu Lin, Changhua Christian Hospital, Changhua.
|
|
| 10:40-11:05 |
Management of Inherited Fibrinogen Disorders.
Speaker: Cecil Ross, St John’s Medical College Hospital, Bengaluru.
|
|
| 11:05-11:30 |
Management of Inherited Platelet Disorders.
Speaker: Simon Otake, Itsbashi Hospital, Tokyo
|
|
| 11:30-12:30 | Scientific Session 11 Theme: Hot Topics |
|
| Co Chairs: Ryosuke Matsuno, Kansai Medical Uiniversity Hospital, Osaka Yi-Feng Wu, Tzu Chi University Hospital, Hualien |
||
| 11:30-11:45 |
Safety, Pharmacokinetics, and Efficacy of NXT007 Prophylaxis in Persons with Hemophilia A without Inhibitors: Primary Analysis of Phase I/II Study (NXTAGE)
Speaker: Yeu-Chin Chen, Tri-Service General Hospital, Taipei
|
|
| 11:45-12:00 |
FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab
Speaker: Allison Wheeler, Washington Center for Bleeding Disorders, Seattle (Virtual)
|
|
| 12:00-12:15 |
VELORA Pioneer: first-in-human safety and PK/PD study of HMB-002 in Type 1 Von Willebrand disease
Speaker: Liane Khoo, Royal Prince Alfred Hospital, Sydney
|
|
| 12:15-12:30 |
In vitro activity of Inno8 in global hemostatic assays alone and with other hemostatic agents
Speaker: Jacob Lund, Novo Nordisk A/S, Malov (Virtual)
|
|
| 12:30-12:40 |
Closing session
|
|
| 12:45 onwards |
Lunch and Departure
|
|
Platinum Sponsor
Gold Sponsor
Bronze Sponsor
Contents will be Updated soon...
Sponsored Symposium
Contents will be Updated soon